These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16461849)

  • 1. Cardiac glycosides and cardiomyopathy.
    Manunta P; Ferrandi M
    Hypertension; 2006 Mar; 47(3):343-4. PubMed ID: 16461849
    [No Abstract]   [Full Text] [Related]  

  • 2. [Alcoholic cardiomyopathy].
    Mono G
    Fortschr Med; 1974 Jul; 92(20):844-8. PubMed ID: 4408525
    [No Abstract]   [Full Text] [Related]  

  • 3. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy.
    Kennedy DJ; Vetteth S; Periyasamy SM; Kanj M; Fedorova L; Khouri S; Kahaleh MB; Xie Z; Malhotra D; Kolodkin NI; Lakatta EG; Fedorova OV; Bagrov AY; Shapiro JI
    Hypertension; 2006 Mar; 47(3):488-95. PubMed ID: 16446397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alcoholic cardiomyopathy and its therapy].
    Poggi M; Palleschi M
    Clin Ter; 1971 Nov; 59(3):261-70. PubMed ID: 5160469
    [No Abstract]   [Full Text] [Related]  

  • 5. [State of the cardiovascular system in chronic renal insufficiency].
    Sumarokov AV; Mikhaĭlov AA; Moiseev VS
    Kardiologiia; 1969 Aug; 9(8):128-35. PubMed ID: 4906927
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alcoholic cardiomyopathy].
    Bayer O; Jost F
    Dtsch Med Wochenschr; 1972 May; 97(18):722-30. PubMed ID: 4259854
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of cardiac glycosides on myocardial contractile proteins].
    Shevchenko AI
    Farmakol Toksikol; 1989; 52(1):40-2. PubMed ID: 2707418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro approach to 'uremic cardiomyopathy'.
    Weisensee D; Löw-Friedrich I; Riehle M; Bereiter-Hahn J; Schoeppe W
    Nephron; 1993; 65(3):392-400. PubMed ID: 8289989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac glycosides and uremia].
    Hevendehl G; Hennemann H; Vaitl F; Heidland A
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1672-5. PubMed ID: 1030076
    [No Abstract]   [Full Text] [Related]  

  • 10. The vetosidum in the treatment of Keshan disease.
    Hsia TY
    Chin Med J (Engl); 1977 Sep; 3(5):315-8. PubMed ID: 411634
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic insufficiency of the heart muscle].
    Spitzbarth H
    Hippokrates; 1968 Jun; 39(11):407-16. PubMed ID: 5733179
    [No Abstract]   [Full Text] [Related]  

  • 12. [Introduction to clinical pharmacodynamics and pharmacokinetics of cardiac glycosides].
    Kudrin AN; Namakanov BA; Davydova ON
    Sov Med; 1981; (11):70-4. PubMed ID: 7038899
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiomyopathy in uremia: hemodynamic and metabolic aspects (author's transl)].
    Drüeke T; Le Pailleur C
    Nephrologie; 1981; 2(2):63-6. PubMed ID: 7290302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cardiac insufficiency with cardiac glycosides].
    Tsyganiĭ AA; Rudenko AF; Kovalev NL; Malinovskiĭ OP; Koziar VV
    Vrach Delo; 1980 Aug; (8):60-3. PubMed ID: 7415132
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential uremic toxins modulate energy metabolism of cardiac myocytes in vitro.
    Weisensee D; Schnaars Y; Schoeppe W; Bereiter-Hahn J; Löw-Friedrich I
    Exp Nephrol; 1997; 5(3):194-200. PubMed ID: 9208278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac glycosides and their use in daily general practice].
    Gaul G
    Med Welt; 1983 Apr; 34(14):452-5. PubMed ID: 6855551
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental uremic cardiomyopathy--fact or fiction?
    Lübbecke F; Steudle V; Schaper J; Wizemann V
    Contrib Nephrol; 1986; 52():134-45. PubMed ID: 3032511
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of the effectiveness of treatment with cardiac glycosides].
    Mukharliamov NM; Tsibekmakher TD
    Kardiologiia; 1975 Jul; 15(7):141-53. PubMed ID: 1206841
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of cardiac glycosides on myocardial contractile function and hemodynamics in a circulatory disorder of children with mitral valve insufficiency].
    Serbin VI; Oskolkova MK; Gasanova AS; Ivanov AP; Dvoriakovskiĭ IV
    Pediatriia; 1981 Mar; (3):22-5. PubMed ID: 7220204
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of chronic cardiac insufficiency with cardiac glycosides].
    Bonelli J
    Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.